Incyte has delivered a pair of pivotal wins for an oral JAK inhibitor in an inflammatory skin condition. But with the placebo ...

Kiromic BioPharma has put 31 people on furlough. The cell therapy biotech has stopped paying the employees, which make up “substantially all” of its workforce, until it raises money to ease its cash ...

It looks like SoftBank's Vision Fund 2 is coming back strong. In the last nearly two quarters, the fund has participated in ...

British-Swedish multinational pharmaceutical and biotechnology company AstraZenica on Monday announced the acquisition of ...

Explore the promising potential of Altimmune, Inc.'s Pemvidutide in NASH, AUD, & obesity treatment, with key trials underway.

SAN MARCOS, CA, USA I March 18, 2025 I SMSbiotech has announced a significant milestone in its pursuit of its regenerative medicine technology, securing ...

BURLINGTON, Mass., March 19, 2025 (GLOBE NEWSWIRE) -- Hyku Biosciences, a pioneer in precision medicine, today announced the appointment of Keith Wilcoxen, PhD, as Chief Scientific Officer. Dr.

Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea ...

Announced the U.S. FDA has accepted our Biologics License Application (BLA) seeking full approval of deramiocel for the treatment of Duchenne ...

SAN FRANCISCO, CA, USA I March 13, 2025 I Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the enrollment of the first patient in its Phase 3 ECLIPSE ...

Why Lorcan O'Herlihy Architects, NBBJ, Gensler, and more are among Fast Company’s Most Innovative Companies in architecture ...